WITNESSETH:Exclusive License Agreement • April 15th, 2004 • Omnicorder Technologies Inc • Measuring & controlling devices, nec • Texas
Contract Type FiledApril 15th, 2004 Company Industry Jurisdiction
EXCLUSIVE LICENSE AGREEMENT for Sanguine Corporation Technologies PHER-02 Oxygen-Carrying Synthetic Substitute for Human Red Blood Cells U.S. Patent Pending, Assigned Serial Number 08/230,672 All Derivatives of PHER-02 TABLE OF CONTENTS RECITALS...Exclusive License Agreement • March 25th, 2002 • Sanguine Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledMarch 25th, 2002 Company Industry Jurisdiction